Clinical Trials Browser

Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasms, Cholangiocarcinoma, Klatskin Tumor, Neoplasm, Residual

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

Lung Neoplasms, Neoplasm, Residual

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Neoplasm, Residual

Neoplasms, Neoplasm, Residual

Neoplasm, Residual

Prostatic Neoplasms, Neoplasm, Residual

Neoplasm, Residual, Neoplasms, Plasma Cell

Leukemia, Myeloid, Acute, Neoplasm, Residual

Neoplasm, Residual

Leukemia, Myeloid, Acute, Neoplasm, Residual

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Neoplasm, Residual

Breast Neoplasms, Neoplasm Metastasis, Neoplasm, Residual

Waldenstrom Macroglobulinemia, Neoplasm, Residual

Multiple Myeloma, Neoplasm, Residual

Neoplasm, Residual

Colonic Neoplasms, Colorectal Neoplasms, Neoplasm, Residual

Gastro-enteropancreatic neuroendocrine tumor, Breast Neoplasms, Melanoma, Neoplasm, Residual

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm, Residual

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Neoplasm, Residual

Neoplasm, Residual

Neoplasm, Residual

Colorectal Neoplasms, Neoplasm, Residual

Skin Neoplasms, Neoplasm, Residual

Clinical Trials

TRACE-BTC

GEMINI Breast

To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)

Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

Caris Biorepository Research Protocol

EURHOLY

Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer

NIRVANA

FERTILAM

Circulating and Urine Tumor DNA Dynamics Predict Minimal Residual Disease and Recurrence Risk in Locally Advanced Upper Tract Urothelial Carcinoma

DUALFLOW

Clear-HPVca

HER2 CR

FIL_BIOWM

Risk-adapted Therapeutic Strategy in +1q NDMM

French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)

French Assessment of MRD by Liquid Biopsies in Stage III CRC Patients (FRENCH.MRD.CRC)

NIP IT!

LumenDx

BRALLA

ctDNA-based Minimal Residual Disease Detection for Resected Pancreatic Adenocarcinoma

Evaluate the Clinical Feasibility of a Novel Neoantigen-Reactive CD8+ T Cell (NART) Detection Technology for Postoperative MRD Surveillance of Pancreatic Cancer

CR1STAL

GUIDE.MRD-01-CRC: Clinical Validation and Benchmarking of Top Performing CtDNA Diagnostics - Colorectal Cancer

ctDNA in Cutaneous Squamous Cell Carcinoma